Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
International Journal of Clinical Practice
|
January 5, 2008
Ezetimibe-associated adverse effects: what the clinician needs to know
M Florentin, E N Liberopoulos, M S Elisaf
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
November 24, 2007
Sibutramine-associated adverse effects: a practical guide for its safe use
M Florentin, E N Liberopoulos, M S Elisaf
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
October 26, 2005
Diagnosis and management of the metabolic syndrome in obesity
E N Liberopoulos, D P Mikhailidis, M S Elisaf
Current Pharmaceutical Design
|
June 23, 2007
Fibrinogen: a predictor of vascular disease
A I Kakafika, E N Liberopoulos, D P Mikhailidis
The Open Cardiovascular Medicine Journal
|
June 11, 2011
Effects of thyroid dysfunction on lipid profile
C V Rizos, M S Elisaf, E N Liberopoulos
Diabetes & Metabolism
|
May 17, 2001
Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus
H J Milionis, E N Liberopoulos, M S Elisaf
Infection
|
October 19, 2011
Lysis syndrome during therapy of visceral leishmaniasis
E N Liberopoulos, A A Kei, M S Elisaf
Current Pharmaceutical Design
|
August 20, 2009
Are the pleiotropic effects of telmisartan clinically relevant?
C V Rizos, M S Elisaf, E N Liberopoulos
International Journal of Clinical Practice
|
March 21, 2013
Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia
A Kei, E N Liberopoulos, D P Mikhailidis, et al.
Current Pharmaceutical Design
|
October 29, 2009
Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome
M Florentin, M S Elisaf, D P Mikhailidis, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
International Journal of Clinical Practice
|
January 5, 2008
Ezetimibe-associated adverse effects: what the clinician needs to know
M Florentin, E N Liberopoulos, M S Elisaf
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
November 24, 2007
Sibutramine-associated adverse effects: a practical guide for its safe use
M Florentin, E N Liberopoulos, M S Elisaf
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
October 26, 2005
Diagnosis and management of the metabolic syndrome in obesity
E N Liberopoulos, D P Mikhailidis, M S Elisaf
Current Pharmaceutical Design
|
June 23, 2007
Fibrinogen: a predictor of vascular disease
A I Kakafika, E N Liberopoulos, D P Mikhailidis
The Open Cardiovascular Medicine Journal
|
June 11, 2011
Effects of thyroid dysfunction on lipid profile
C V Rizos, M S Elisaf, E N Liberopoulos
Diabetes & Metabolism
|
May 17, 2001
Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus
H J Milionis, E N Liberopoulos, M S Elisaf
Infection
|
October 19, 2011
Lysis syndrome during therapy of visceral leishmaniasis
E N Liberopoulos, A A Kei, M S Elisaf
Current Pharmaceutical Design
|
August 20, 2009
Are the pleiotropic effects of telmisartan clinically relevant?
C V Rizos, M S Elisaf, E N Liberopoulos
International Journal of Clinical Practice
|
March 21, 2013
Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia
A Kei, E N Liberopoulos, D P Mikhailidis, et al.
Current Pharmaceutical Design
|
October 29, 2009
Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome
M Florentin, M S Elisaf, D P Mikhailidis, et al.
Page
of 4